Cancer Research UK National Biomarker Centre

*Invitation to Clinical Trial Professionals in the UK and EU* We invite you to participate in an important survey for the UpSMART Accelerator Programme. Led by the CRUK National Biomarker Centre's Digital Cancer Research Team, this international initiative leverages digital innovations to enhance early-phase cancer medicine trials. To create solutions that truly meet your needs, we are using a design thinking approach. This focuses on understanding users' needs, defining clear objectives, and continuously refining our solutions based on real feedback. Work Package 3 of this project aims to develop training resources and a chatbot AI assistant to support professionals in planning and conducting Clinical Trials of Digital Healthcare Products (DHPs). Your insights are invaluable, and we would greatly appreciate your participation in a brief survey. Please complete our survey by the 31st of July 2024. It takes no more than 10 minutes, and your responses will directly influence the development of these tools. Survey Link: https://lnkd.in/ezZH8iXP For more information, visit our website: https://lnkd.in/e4Kjz-4a Thank you for your time and insights. Please share this survey with interested colleagues and reach out with any questions. #ClinicalTrials #DigitalHealth #ResearchInnovation #UpSMART #CRUK #HealthcareInnovation

Today was our official launch and what. A. Day! Thank you to all our funders, donors, collaborators & friends for joining us. We absolutely loved seeing you all and celebrating our launch. We were absolutely honoured to welcome Andy Burnham to our labs, thank you for visiting us! The biggest thank you to the patients who visited us this morning. You are the reason we do what we do & we had the best morning with you. We hope we can welcome more patients in the future to share our work. We had an absolutely wonderful day and will share more moments over the coming days!

Exciting news! Today marks the opening of the Cancer Research UK National Biomarker Centre, which is housed at the new Paterson Building in Manchester – also home to our Cancer Research UK Manchester Institute. The facility will help experts detect cancer at an earlier stage, when treatments are more likely to be successful, and will provide other clues about a person’s cancer, which could help personalise their treatment options. This comes as part of our ongoing investment of £25m in Manchester. We’re putting the city at the heart of our mission to beat cancer 🐝💙

The new Cancer Research UK National Biomarker Centre will officially open in Manchester later today. Ahead of its opening, I’ve noted down a few thoughts on the role of biomarkers in cancer research and how this facility will support our researchers. 

Well done Yitao!

We're super excited to announce our official launch will take place on the 14th June! 🤩 And our new website has launched today! 🎉 https://cruknbc.org/ We plan to grow our website over the next few months so keep a look out!

We are recruiting Bioinformaticians/Computational Biologists to join our Bioinformatics and Biostatistics Team!   You will have the opportunity to work alongside a multidisciplinary team of clinicians, biologists, statisticians, bioinformaticians and computational scientists to analyse genomic, epigenomic and transcriptomic data arising from patient samples.   The focus will be to implement/further develop bioinformatics pipeline and/or computational tools, and apply them to sequencing data generated across many exciting projects! Interest peaked?  Find out more and apply (before the 5th May!) via https://lnkd.in/djj2WKK

We have an exciting opportunity for an Executive Assistant to join us and become an integral part of the Director’s office. In addition to providing support to the Director, you'll be at the heart of the Centre’s operations, ensuring the efficient day-to-day running of the Director’s Office as well as supporting with the Centre’s wider administrative tasks. So if you're an agile and proactive multitasker, who is looking to join a busy and vibrant office then apply before the 30th April via https://lnkd.in/djj2WKK

We, alongside our clinical colleagues at The Christie Hospital, have developed a blood test to determine the primary tumour for patients with Cancers of Unknown Primary (CUP) addressing an unmet medical need. Meet CUPiD - our machine learning classifier with accurate tissue-of-origin (TOO) predictions across 29 tumour classes. We tested CUPiD on 143 cfDNA samples from patients with 13 cancer types alongside 27 non-cancer controls, with overall sensitivity of 84.6% and TOO accuracy of 96.8%. CUPiD has the potential to give patients with hard to treat cancer access to personalised medicines & improve clinical outcomes and you can read more about our latest research in our Nature Communications paper! https://rdcu.be/dE7u4